自体造血细胞移植治疗NK/T细胞血管内淋巴瘤患者的长期缓解。

IF 0.9 Q4 HEMATOLOGY

Journal of Clinical and Experimental Hematopathology Pub Date : 2025-01-01 DOI:10.3960/jslrt.24068

Hiroki Tsutsumi, Keisuke Tanaka, Atsushi Hamamura, Norihiko Nakamura, Shigeo Toyota

{"title":"自体造血细胞移植治疗NK/T细胞血管内淋巴瘤患者的长期缓解。","authors":"Hiroki Tsutsumi, Keisuke Tanaka, Atsushi Hamamura, Norihiko Nakamura, Shigeo Toyota","doi":"10.3960/jslrt.24068","DOIUrl":null,"url":null,"abstract":"Intravascular lymphoma (IVL) is a rare subtype of lymphoma, mostly of B-cell origin. A few cases of IVL have been reported as having NK/T cell origins (IVNKTL). These cases are known to be fatal, especially when systemic symptoms are present. We report the case of a patient of IVNKTL who was refractory to initial treatment and received autologous hematopoietic stem cell transplantation (auto-HSCT). She has maintained complete remission (CR) for over eight years. Our case might support the evidence of auto-HSCT for the treatment of IVNKTL with chemosensitivity.","PeriodicalId":45936,"journal":{"name":"Journal of Clinical and Experimental Hematopathology","volume":"65 1","pages":"62-67"},"PeriodicalIF":0.9000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051424/pdf/","citationCount":"0","resultStr":"{\"title\":\"Long-term remission in a patient with NK/T cell intravascular lymphoma with autologous hematopoietic cell transplantation.\",\"authors\":\"Hiroki Tsutsumi, Keisuke Tanaka, Atsushi Hamamura, Norihiko Nakamura, Shigeo Toyota\",\"doi\":\"10.3960/jslrt.24068\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Intravascular lymphoma (IVL) is a rare subtype of lymphoma, mostly of B-cell origin. A few cases of IVL have been reported as having NK/T cell origins (IVNKTL). These cases are known to be fatal, especially when systemic symptoms are present. We report the case of a patient of IVNKTL who was refractory to initial treatment and received autologous hematopoietic stem cell transplantation (auto-HSCT). She has maintained complete remission (CR) for over eight years. Our case might support the evidence of auto-HSCT for the treatment of IVNKTL with chemosensitivity.\",\"PeriodicalId\":45936,\"journal\":{\"name\":\"Journal of Clinical and Experimental Hematopathology\",\"volume\":\"65 1\",\"pages\":\"62-67\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051424/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical and Experimental Hematopathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3960/jslrt.24068\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Experimental Hematopathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3960/jslrt.24068","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

血管内淋巴瘤（IVL）是一种罕见的淋巴瘤亚型，主要来自b细胞。一些IVL病例被报道为NK/T细胞起源（IVNKTL）。已知这些病例是致命的，特别是当出现全身性症状时。我们报告了一例IVNKTL患者，最初治疗难治，接受了自体造血干细胞移植（auto-HSCT）。她保持完全缓解（CR）超过8年。我们的病例可能支持自体造血干细胞移植治疗化疗敏感的IVNKTL的证据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Long-term remission in a patient with NK/T cell intravascular lymphoma with autologous hematopoietic cell transplantation.

Intravascular lymphoma (IVL) is a rare subtype of lymphoma, mostly of B-cell origin. A few cases of IVL have been reported as having NK/T cell origins (IVNKTL). These cases are known to be fatal, especially when systemic symptoms are present. We report the case of a patient of IVNKTL who was refractory to initial treatment and received autologous hematopoietic stem cell transplantation (auto-HSCT). She has maintained complete remission (CR) for over eight years. Our case might support the evidence of auto-HSCT for the treatment of IVNKTL with chemosensitivity.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Clinical and Experimental Hematopathology HEMATOLOGY-

CiteScore

2.00

自引率

6.70%

发文量

审稿时长

11 weeks